Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Takeda Pharmaceutical Company Limited American Depositary Shares (each
(NY:
TAK
)
20.95
+0.93 (+4.67%)
Delayed Quote
Updated: 1:55 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Is BioCryst a Good Stock to Buy Now?
↗
May 21, 2021
This commercial-stage drugmaker trades for less than many of its clinical-stage peers.
Via
The Motley Fool
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
May 21, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
May 21, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Better Mood Day
↗
May 20, 2021
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.
Via
Talk Markets
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML
May 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
May 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day
↗
May 14, 2021
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...
Via
Benzinga
Takeda FY20 Profit Surges, Revenue Drops; Guides For Weak FY21 Profit
↗
May 11, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) reported an FY20 net profit of ¥376 billion, a 750% Y/Y increase, reflecting gains on non-core asset sales and...
Via
Benzinga
Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares
↗
May 12, 2021
Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the...
Via
Benzinga
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
May 11, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
↗
May 10, 2021
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:
Via
Benzinga
Gold Up Four Days In A Row
↗
May 10, 2021
The dollar is at a nearly 3 month low.
Via
Talk Markets
Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com
↗
May 09, 2021
Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA...
Via
Benzinga
Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip
↗
May 06, 2021
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday. SKLZ shares closed 9% lower...
Via
Benzinga
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
↗
May 07, 2021
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...
Via
Benzinga
Monday Markets Unhinged
↗
May 03, 2021
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.
Via
Talk Markets
Another Heavy News Day
↗
April 29, 2021
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.
Via
Talk Markets
Arrowhead's ARO-AAT Treatment Associated With Improved Fibrosis In Patients With Alpha-1 Liver Disease
↗
April 28, 2021
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has announced positive interim 48-week liver biopsy results from the Phase 2 AROAAT2002 study ...
Via
Benzinga
Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
April 28, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
April 27, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Down Nearly 50% From All-Time Highs, Is This Pharma Giant a Good Buy?
↗
April 24, 2021
You might want to consider adding this company to your portfolio.
Via
The Motley Fool
Friday Market Report
↗
April 23, 2021
Schlumberger Ltd of Curação today reported on its Q1 results which were good.
Via
Talk Markets
Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions
↗
April 19, 2021
Ovid Therapeutics Inc (NASDAQ: OVID) has announced to discontinue the development of OV101 (gaboxadol), a delta (δ)-selective GABAA receptor agonist, in...
Via
Benzinga
Electric Cancer Cure
↗
April 13, 2021
Most US stocks were down on fear of inflation and financial risks but then rose after lunch.
Via
Talk Markets
Takeda Manufacturing Site in Belgium Pioneering Wastewater Recycling for Production
April 13, 2021
SOURCE: Takeda
Via
3BL Media
Daily Stock Analysis: Takeda Pharmaceutical (TAK)
↗
April 09, 2021
Takeda Pharmaceutical Co Ltd's price per share closed at $17.06 yesterday. One year ago its price was $16.05. Price per share has increased about 6.3% from the midst of the COVID market slump.
Via
Talk Markets
Weak Markets - Yom HaShoah
↗
April 07, 2021
Today the Biden Administration revealed its planned changes in the corporate tax code.
Via
Talk Markets
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
